Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs113642700 | chr7:1105654 | C/T | 0.000262 | 173 | 25.87 | 24.95 | 49.58 | KM Plot |
PCPG | rs113656186 | chr17:74700236 | T/C | 0.000168 | 177 | 25.97 | 19.57 | 13.5 | KM Plot |
PCPG | rs113664491 | chr2:2743986 | TGAG/T | 3.49E-5 | 173 | 25.6 | 23.43 | 21.68 | KM Plot |
PCPG | rs113680450 | chr14:74645271 | G/A | 0.000221 | 176 | 25.28 | 26.57 | 10.57 | KM Plot |
PCPG | rs11369847 | chr4:78948974 | A/AG | 4.92E-5 | 174 | 39 | 25.43 | 25.47 | KM Plot |
PCPG | rs113705040 | chr20:6008115 | G/A | 0 | 177 | 25.47 | 23.08 | 2.93 | KM Plot |
PCPG | rs113738647 | chr17:65777816 | CA/CAA | 0.000476 | 171 | 24.85 | 34.37 | 8.22 | KM Plot |
PCPG | rs113769187 | chr2:242529953 | T/G | 4.87E-11 | 176 | 25.87 | 24.7 | 10.3 | KM Plot |
PCPG | rs113771837 | chr7:158875073 | G/A | 0 | 176 | 25.28 | 41.8 | 3.17 | KM Plot |
PCPG | rs113775385 | chr16:71453423 | C/T | 0.000124 | 178 | 24.52 | 26.65 | 43.12 | KM Plot |
PCPG | rs11378972 | chr16:87318563 | C/CA | 0.000144 | 170 | 23.53 | 29.13 | 3.17 | KM Plot |
PCPG | rs113813244 | chr20:6023390 | C/T | 0 | 178 | 25.53 | 23.08 | 2.93 | KM Plot |
PCPG | rs11381342 | chr6:123124049 | A/AG | 2.98E-6 | 176 | 8.67 | 27.23 | 24.85 | KM Plot |
PCPG | rs11383891 | chr16:89574595 | C/CA | 0.000356 | 176 | 26.78 | 25.28 | 19.53 | KM Plot |
PCPG | rs113851179 | chr16:1733479 | C/CT | 0 | 173 | 25.6 | 15.85 | 2.93 | KM Plot |